WHO ICTRP trial
A Multicenter, Open Label, Comparative Study to Evaluate the Efficacy of a New…
CTRI/2010/091/000496 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2010/091/000496 |
|---|---|
| Public title | A Multicenter, Open Label, Comparative Study to Evaluate the Efficacy of a New Fully Liquid Hexavalent DTwP-Hepb-Hib-IPV Vaccine (EasysixTM, Panacea Biotec Ltd.) in Healthy Infants. |
| Scientific title | A Randomized, Multicenter, Open Label, Comparative Study to Evaluate the Immunogenicity and Reactogenicity of a New Fully Liquid Hexavalent DTwP-Hepb-Hib-IPV Vaccine (EasysixTM, Panacea Biotec Ltd.) with Pentavalent DTwP-Hepb/Hib Vaccine (Tritanrix-HBTM Reconstituted with HiberixTM, GSK) Co… |
| Primary sponsor | Panacea Biotec Limited |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 2/ Phase 3 |
| Countries | India |
| Interventions | Intervention1: new fully liquid hexavalent DTwP-HepB-Hib-IPV vaccine (EasysixTM, Panacea Biotec Ltd.): Three doses(0.5 ml each) at 6, 10 and 14 weeks of age. Control Intervention1: pentavalent DTwP-HepB/Hib vaccine (Tritanrix-HBTM… |
| Registration date | Feb 18, 2011 |
| Target size | 666 |
| Secondary IDs | PBL/CR/0012008/CT |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: